T1	Intervention 719 764	switched from CFC albuterol to HFA albuterol.
T2	Intervention 766 856	atients with asthma stabilized on CFC albuterol during a 12-week safety and efficacy trial
T3	Intervention 873 998	to either continue receiving CFC albuterol or to be switched to receive HFA albuterol in a yearlong safety and efficacy trial
